Delivery Order SPE2DB22D3501-SPE2DB25FUZ23
Award Date
3/20/25
Potential Completion Date
3/21/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB20D1004|SPE2DB24FF5V7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4563925353 Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, with a ceiling value of $5,222.75. This is a Firm Fixed Price Delivery Order contract with a completion date of March 12, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award, SPE2DB20D7059|SPE2DB24FPTK1, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a ceiling value of $1,075.70 and an ultimate completion date of October 23, 2023. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract was not set...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,371.32 and covers the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FET14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,798.14 contract is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a completion date of December 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award, identified as SPE2DB20D3505|SPE2DB25FT7S1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,891.97, is for the delivery of 4566875567 units of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of January 9, 2025. The contract is not designated as...
This federal contract award, identified as SPE2DB22D1106|SPE2DB25FDTF5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with a ceiling value of $4,556.22 and a period of performance through January 7, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUX64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.69 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is not designated as a set-aside and has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999...
This federal contract award, SPE2DB22D3004|SPE2DB25FNZ73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.47 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
The federal contract award, SPE2DX15D1053|SPE2DX25F6DGC, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,428.97 Firm Fixed Price Delivery Order is for the supply of FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of November 14, 2024 and is not set aside for any specific business category....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,712.02 firm fixed-price delivery order is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025 and was awarded on January 3, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...